Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study

Rebekka Lund Hansen, Tanja Schoedt Jorgensen, Lene Dreyer, Merete L. Hetland, Bente Glintborg, Johan Askling, Daniela Di Giuseppe, Lennart T. H. Jacobsson, Johan K. Wallman, Dan Nordström, Kalle Aaltonen, Eirik K. Kristianslund, Tore K. Kvien, Sella A. Provan, Bjorn Gudbjornsson, Thorvadur J. Love, L. E. Kristensen

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalRheumatology
Volume60
Issue number1
Pages (from-to)140-146
Number of pages7
ISSN1462-0324
DOIs
Publication statusPublished - Jan 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • psoriatic arthritis
  • bDMARDs
  • prescription patterns
  • international collaborations
  • secular trends of inflammatory hallmarks
  • ANTITUMOR NECROSIS FACTOR
  • TREATMENT RECOMMENDATIONS
  • EULAR RECOMMENDATIONS
  • THERAPY
  • MANAGEMENT
  • INHIBITOR
  • EFFICACY
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this